ROE accretion from acquisitions combined with an upswing in the technology cycle; J.P.Morgan raises CICC-H's target price and maintains its top-pick view

Overview

This is a J.P.Morgan company research report on China International Capital Corporation Ltd (03908.HK). Its core conclusion is that the acquisitions by CICC-H are unlikely to dilute ROE over the long term; instead, they could generate ROE accretion through a better market environment, capital redeployment, cross-selling in wealth management, and recovery in institutional business. Meanwhile, the financing cycle in China's technology sector will provide upside momentum for investment banking, IPO placement gains, and private equity investment returns.

Core views

The report identifies three key bullish drivers for CICC-H. First, CICC has a leading investment banking franchise, ranking among the top players in A-share and H-share IPO market share year-to-date in early 2026 and participating extensively in technology-company listings and financing. Second, regulators have taken a more supportive stance toward securities firms' institutional business since 2025; given CICC's high exposure to this business, it should benefit more directly. Third, the acquisitions of Cinda Securities and Dongxing Securities can supplement capital, regional branches, and retail client bases, while improving earnings and ROE through cross-selling of wealth management products and capital redeployment.

Analysis framework

The report combines a top-down analysis with company-specific scenario modeling. It first analyzes China's technology cycle, IPO policies, trading activity, and regulatory changes affecting institutional business, then assesses CICC's relative strengths in investment banking, overseas business, and wealth management. It subsequently models 2027E ROE in the base and bull cases using assumptions for post-acquisition leverage, ADT, wealth management revenue contribution, the client bases of the two acquired securities firms, and other synergies. For valuation, it derives the target price using DDM and ROE-g/COE-g frameworks.

Methodology notes

• Valuation methodsDDM and ROE-g/COE-g

  Dividend discount and terminal value valuation

  The target price is based on a DDM of FY26-28E dividends, combined with the ROE-g/COE-g approach to estimate terminal value. Key assumptions include a 1.8% risk-free rate, an 8.0% equity risk premium, a 1.15x beta, and a 4.5% long-term growth rate.

• scenario_analysisbase-case and bull-case ROE scenario

  ROE scenario modeling

  The base case assumes 2026E ADT of Rmb2.5trn, leverage rising to 6.1x in 2027E, and total acquisition synergies contributing approximately 1.2 percentage points to ROE. The bull case assumes ADT remains at Rmb2.7trn from the second half of 2026, leverage rises to 6.6x in 2027E, and synergies contribute approximately 2.4 percentage points to ROE.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• 03908.HK

  Covered name; J.P.Morgan maintains Overweight and raises its target price

  Strengths

  Leading investment banking franchise, high A-share and H-share IPO market share, strong participation in technology-company financing, relatively high overseas revenue contribution, and strong wealth management product capabilities.

  Weaknesses

  The acquisitions create share dilution and integration execution pressure, while growth in capital-intensive businesses could create refinancing risks.

  Comparison

  Compared with Dongxing Securities and Cinda Securities, CICC is stronger in mid- to high-end investment banking, international business, and wealth management products. The two acquired securities firms can complement CICC through their retail clients, regional networks, and capital positions.

  Risks

  A sharp market correction, suspension of IPO reviews, government requirements for contributions to stabilization funds, and potential equity financing and dilution resulting from expansion of capital-intensive businesses.

• Cinda Securities

  Potential acquisition target and source of synergies

  Strengths

  Retail business foundation, regional network, and relatively stronger capital position.

  Weaknesses

  Wealth management product sales contribute less than at CICC, requiring post-acquisition cross-selling and integration to improve efficiency.

  Comparison

  Complementary to CICC, which can provide wealth management products and asset allocation capabilities.

  Risks

  Customer conversion, cross-selling of products, and the pace of business integration may fall short of expectations.

• Dongxing Securities

  Potential acquisition target and source of synergies

  Strengths

  Retail business foundation, regional network, and relatively stronger capital position.

  Weaknesses

  Wealth management product sales contribute less than at CICC, requiring post-acquisition cross-selling and integration to improve efficiency.

  Comparison

  Complementary to CICC, which can provide wealth management products and asset allocation capabilities.

  Risks

  Uncertainty remains over the pace of integration, the realization of synergies, and the effectiveness of capital redeployment.

Key data

• Current priceHK$20.54Price of 3908.HK on June 29, 2026.
• Target priceHK$28.50Raised from the previous target price of HK$24.50, with the valuation date rolled forward to Jun-2027.
• Implied upside39%Based on the current price and new target price.
• 2027E ROE base case11.3%Above the Bloomberg consensus estimate of 10.2%.
• 2027E ROE bull case13.5%Assumes ADT and market sentiment remain elevated from the second half of 2026.
• 2026-28E earnings revisions+7% / +12% / +10%The report raises its 2026E, 2027E, and 2028E earnings forecasts.
• 2026E ADT base assumptionRmb2.5trnAssumes a decline from Rmb2.7trn in the first half of 2026 to approximately Rmb2.3trn in the second half of 2026.
• Recent valuation0.67x forward P/BBelow the 1.0-1.3x forward P/B range during the 2020-21 bull market.

Impact & implications

If the report's thesis materializes, the investment case for CICC-H will shift from concerns about dilution from the acquisitions toward ROE recovery and valuation re-rating. Upward revisions to consensus expectations, active IPOs and financing by technology companies, policy support for institutional business, and higher overseas revenue contribution could all serve as share-price catalysts. From a valuation perspective, J.P.Morgan believes that a recovery of 2027E ROE to 11.3% could support a re-rating of P/B toward 1.0x forward P/B.

Risks

• A material market correction could trigger government intervention, contributions to stabilization funds, or a suspension of IPO reviews.
• Stronger-than-expected growth in capital-intensive businesses could create equity financing needs and dilution risks.
• Acquisition synergies, cross-selling of wealth management products, or capital redeployment could fall short of the report's assumptions.
• ADT and market sentiment may not be sustained, causing investment banking, brokerage, trading, and investment income to fall below expectations.
• If the regulatory environment tightens again, recovery in institutional business and valuation re-rating could be hindered.

What to watch

• Whether ADT remains near the report's assumptions in the second half of 2026 and in 2027.
• Changes in capital deployment and leverage following completion of CICC's acquisitions of Cinda Securities and Dongxing Securities.
• The pace of technology-company IPOs in the A-share and H-share markets, project pipeline, and CICC's market share.
• Revenue contribution from cross-selling wealth management products to clients of the acquired securities firms.
• Whether 2027E ROE in Bloomberg consensus estimates is revised upward toward J.P.Morgan's 11.3% forecast.
• Whether CICC-H's forward P/B re-rates from the recent 0.67x toward 1.0x.